OpenAI Nears $100 Billion Funding Round at $850 Billion Valuation: Bloomberg Report 
Goldman Sachs Reportedly Drops Diversity Criteria From Board Candidate Evaluations 
Stock Market Movers: NVIDIA and Meta Expand AI Partnership as Cadence Surges on Earnings 
Qualcomm to Invest $150 Million in India AI Startups, Strengthening Presence in Growing Market 
Microsoft Plans $50 Billion AI Investment to Accelerate Growth in the Global South 
Vietnam Airlines, Vietjet, and Sun PhuQuoc Airways Sign Major Boeing Aircraft Deals Amid U.S.–Vietnam Trade Talks 
Hedge Funds Cut Nvidia, Amazon and Microsoft Stakes as AI Valuation Concerns Rise 
Mark Zuckerberg Testifies in Youth Social Media Addiction Trial Over Instagram Policies 
Medical Groups Sue FTC Over Gender-Affirming Care Investigations Amid Trump Policy Dispute 
Boeing Secures 50 737 MAX Jet Order from Vietnam Airlines Amid Expanding Global Demand 
Starboard Value Targets Tripadvisor Board Overhaul Amid Stock Slump 
European IT Hardware Stocks to Watch as Gaming Demand Outpaces Smartphones, Says BofA 
Yotta to Build $2 Billion AI Data Centre Hub in India with Nvidia Blackwell Ultra Chips 
Freedom Finance and Binance Join Forces in Digital Assets 
Luxury Stocks Face Volatility as AI Market Swings and Hedge Fund Bets Rattle LVMH and Kering 
IRVINE, Calif., May 03, 2018 -- Evolus, Inc. (NASDAQ:EOLS) (“Evolus”), a lifestyle aesthetics company focused on delivering advanced aesthetic procedures and treatments to physicians and consumers, today announced that Murthy Simhambhatla, President and Chief Executive Officer is scheduled to present at the Bank of America Merrill Lynch 2018 Health Care Conference in Las Vegas, NV.
Event: Bank of America Merrill Lynch 2018 Health Care Conference
Date: Thursday, May 17, 2018
Time: 10:00 a.m. PT
Location: The Encore, Las Vegas, NV
An audio webcast of the Company’s presentation will be available on the investor relations section of Evolus’ website at www.Evolus.com. A replay of the webcast will be available for 90 days after the date of the presentation.
The Company will also be hosting one-on-one investor meetings at the conference on Wednesday, May 16. If interested in meeting with management, please reach out to Brian Johnston at [email protected] or your Bank of America Merrill Lynch contact.
About Evolus, Inc.
Evolus is a medical aesthetics company dedicated to bringing advanced aesthetic procedures and treatments to physicians and consumers. Evolus focuses on the self-pay aesthetic market and its lead product candidate DWP-450 (prabotulinumtoxinA), an injectable 900 kDa purified botulinum toxin type A complex.
Evolus Contacts:
Media:
Kirsten Thomas, The Ruth Group
Tel: +1-508-280-6592
Email: [email protected]
Investor Contact:
Brian Johnston, The Ruth Group
Tel: +1 646-536-7028
Email: [email protected]
